Keyphrases
Clinical Model
100%
Immune-related
100%
Nephrotoxicity
100%
Drug-induced Kidney Injury
100%
Kidney
75%
Cancer Patients
50%
Quantitative Systems Pharmacology
50%
Anti-tumor Response
50%
Preclinical Testing
50%
Drug Disposition
50%
Kidney Toxicity
50%
Immune System
50%
T Cells
25%
Cancer Center
25%
Mouse Model
25%
Translational Impact
25%
Mechanism Evaluation
25%
Therapeutic Response
25%
Inhibitory Receptors
25%
CD8+
25%
Glomerular Filtration Rate
25%
Target Response
25%
Subclinical Injury
25%
Pharmacokinetic Modeling
25%
Kidney Biology
25%
New-onset Chronic Kidney Disease
25%
Immunotoxicity
25%
Specific Intent
25%
Serum Creatinine
25%
ICI Therapy
25%
Cancer Treatment
25%
Chronic Kidney Disease
25%
Clinical Patients
25%
Clinical Practice
25%
Unmet Needs
25%
Testing Practices
25%
Acute Kidney Injury
25%
Human Biospecimens
25%
Tumor Subtype
25%
Checkpoint Inhibitors
25%
Tubulointerstitial Nephritis
25%
Exposure Kinetics
25%
Drug Exposure
25%
Renal Pathology
25%
Lymphocyte Signaling
25%
Immune Response
25%
Humanized Animal Model
25%
Mouse Tumor Model
25%
Kidney Decline
25%
Proteomics
25%
CD4+
25%
Immunology
25%
Pharmacokinetics
25%
Pharmacokinetic-pharmacodynamic Modeling
25%
Patient's Will
25%
Biological Drugs
25%
Kidney Injury
25%
Immunomodulatory Drugs (IMiDs)
25%
Nephrology
25%
Multidisciplinary Team
25%
Medicine and Dentistry
Nephrotoxicity
100%
Kidney Injury
100%
Immunity
100%
Malignant Neoplasm
50%
Drug Disposition
33%
Chronic Kidney Disease
33%
Pharmacokinetics
33%
T Lymphocyte
16%
Acute Kidney Injury
16%
Interstitial Nephritis
16%
Glomerular Filtration Rate
16%
Cancer Model
16%
Lymphocyte Signaling
16%
Neoplasm
16%
Immunology
16%
Renal Pathology
16%
Immunotoxicity
16%
Creatinine
16%
Immunomodulatory Drug
16%
Nephrology
16%
Biological Product
16%
Drug Exposure
16%
Cancer Therapy
16%
Treatment Response
16%
Pharmacodynamics
16%
CD8 Antigen
16%
Receptor
16%
Cancer
16%
Proteomics
16%
Immune System
16%
Pharmacology, Toxicology and Pharmaceutical Science
Kidney Injury
100%
Nephrotoxicity
100%
Malignant Neoplasm
66%
Chronic Kidney Failure
33%
Mouse Model
16%
Acute Kidney Failure
16%
Neoplasm
16%
Pharmacokinetic Modeling
16%
Immunotoxicity
16%
Biological Product
16%
Pharmacodynamic Modeling
16%
Interstitial Nephritis
16%
Creatinine
16%
Cancer Model
16%
CD8 Antigen
16%
Quantitative Systems Pharmacology Modeling
16%
Receptor
16%
Pharmacokinetics
16%